SEQUENCE-SPECIFIC INTERACTION OF THE ETS1 PROTEIN WITH THE LONG TERMINAL REPEAT OF THE HUMAN T-LYMPHOTROPIC VIRUS TYPE-I

被引:74
作者
GITLIN, SD
BOSSELUT, R
GEGONNE, A
GHYSDAEL, J
BRADY, JN
机构
[1] NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
[2] INST CURIE,BIOL SECT,ONCOL VIRALE & CELLULAIRE LAB,F-91405 ORSAY,FRANCE
关键词
D O I
10.1128/JVI.65.10.5513-5523.1991
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We recently demonstrated that members of the c-ets proto-oncogene family, Ets1 and Ets2, are sequence-specific transcriptional activators of the human T-lymphotropic virus type I (HTLV-I) long terminal repeat (LTR). We now report that the HTLV-I LTR contains two distinct Ets1-responsive regions, ERR-1 and ERR-2. Expression of Ets1 with reporter plasmids containing ERR-1 or ERR-2 upstream of a basal promoter resulted in an increase in transcriptional activity. By gel mobility shift assay, the interaction of Ets1 with the downstream ERR-1-binding region was found to be more stable than its interaction with the upstream ERR-2 region. By DNase I footprint, gel mobility shift, and methylation interference analyses, ERR-1 was found to contain two Ets1 binding sites, ERE-A and ERE-B. A recombinant Ets1 protein was found to bind with higher affinity to ERE-A than to ERE-B. Binding of Ets1 to these sites appears to result in a specific and sequential protection of a 37-nucleotide sequence of the HTLV-I LTR from -154 to -118. In view of the high-level expression of Ets1 in lymphoid cells, the c-ets proto-oncogenes encode transcription factors which could play an important role in both basal and Tax1-mediated HTLV-I transcription.
引用
收藏
页码:5513 / 5523
页数:11
相关论文
共 77 条
[1]   TRYPTOPHANS IN MYB PROTEINS [J].
ANTON, IA ;
FRAMPTON, J .
NATURE, 1988, 336 (6201) :719-719
[2]   ENZYMATIC AMPLIFICATION OF EXOGENOUS AND ENDOGENOUS RETROVIRAL SEQUENCES FROM DNA OF PATIENTS WITH TROPICAL SPASTIC PARAPARESIS [J].
BANGHAM, CRM ;
DAENKE, S ;
PHILLIPS, RE ;
CRUICKSHANK, JK ;
BELL, JI .
EMBO JOURNAL, 1988, 7 (13) :4179-4184
[3]   DETECTION OF HUMAN T-CELL LYMPHOMA LEUKEMIA-VIRUS TYPE-I DNA AND ANTIGEN IN SPINAL-FLUID AND BLOOD OF PATIENTS WITH CHRONIC PROGRESSIVE MYELOPATHY [J].
BHAGAVATI, S ;
EHRLICH, G ;
KULA, RW ;
KWOK, S ;
SNINSKY, J ;
UDANI, V ;
POIESZ, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) :1141-1147
[4]   RECIPROCAL EXPRESSION OF HUMAN ETS1 AND ETS2 GENES DURING T-CELL ACTIVATION - REGULATORY ROLE FOR THE PROTOONCOGENE ETS1 [J].
BHAT, NK ;
THOMPSON, CB ;
LINDSTEN, T ;
JUNE, CH ;
FUJIWARA, S ;
KOIZUMI, S ;
FISHER, RJ ;
PAPAS, TS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3723-3727
[5]  
BHAT NK, 1989, J IMMUNOL, V142, P672
[6]   TEMPORAL AND TISSUE-SPECIFIC EXPRESSION OF MOUSE ETS GENES [J].
BHAT, NK ;
FISHER, RJ ;
FUJIWARA, S ;
ASCIONE, R ;
PAPAS, TS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3161-3165
[7]   VIRAL MYB ONCOGENE ENCODES A SEQUENCE-SPECIFIC DNA-BINDING ACTIVITY [J].
BIEDENKAPP, H ;
BORGMEYER, U ;
SIPPEL, AE ;
KLEMPNAUER, KH .
NATURE, 1988, 335 (6193) :835-837
[8]   ELECTROPHORETIC TRANSFER OF PROTEINS AND NUCLEIC-ACIDS FROM SLAB GELS TO DIAZOBENZYLOXYMETHYL CELLULOSE OR NITROCELLULOSE SHEETS [J].
BITTNER, M ;
KUPFERER, P ;
MORRIS, CF .
ANALYTICAL BIOCHEMISTRY, 1980, 102 (02) :459-471
[9]   A BETA-GALACTOSIDASE HYBRID PROTEIN TARGETED TO NUCLEI AS A MARKER FOR DEVELOPMENTAL STUDIES [J].
BONNEROT, C ;
ROCANCOURT, D ;
BRIAND, P ;
GRIMBER, G ;
NICOLAS, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) :6795-6799
[10]   THE PRODUCT OF THE C-ETS-1 PROTOONCOGENE AND THE RELATED ETS2 PROTEIN ACT AS TRANSCRIPTIONAL ACTIVATORS OF THE LONG TERMINAL REPEAT OF HUMAN T-CELL LEUKEMIA-VIRUS HTLV-1 [J].
BOSSELUT, R ;
DUVALL, JF ;
GEGONNE, A ;
BAILLY, M ;
HEMAR, A ;
BRADY, J ;
GHYSDAEL, J .
EMBO JOURNAL, 1990, 9 (10) :3137-3144